Final answer:
The client's understanding of Rho(D) immune globulin administration is correct only if they recognize the need for the medication in cases of an Rh-positive baby, not an Rh-negative one, and also for procedures that risk fetal blood entering the maternal circulation, such as amniocentesis.
Step-by-step explanation:
Understanding the Rho(D) immune globulin, also known as RhoGAM, is crucial for Rh-negative individuals. When examining the true/false statements made by a client to indicate an understanding of the teaching:
- Statement a) "I will receive this medication if my baby is Rh-negative" is False. Rho(D) immune globulin is given when the baby is Rh-positive to prevent the development of anti-Rh antibodies in the mother.
- Statement b) "I will receive this medication when I am in labor" is False. Rho(D) immune globulin is usually administered around the 26-28th week of pregnancy and within 72 hours after delivery.
- Statement c) "I will need a second dose of this medication when my baby is 6 weeks old" is False. The second dose is typically given within 72 hours after birth, not at 6 weeks.
- Statement d) "I will need this medication if I have an amniocentesis" is True. Rho(D) immune globulin may be given after procedures like amniocentesis that could lead to transplacental hemorrhage.